Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
76,81,96,97 The main factor contributing to the lack of greater investment in lixisenatide and other short-acting agents for MASLD may be their influence on metabolic function, including pharmacokinetic differences induced by a single-dose method and their effects on gastric emptying, 91 which could limit their effectiveness in improving glycolipid metabolism
60 PetersenABKnopFKChristensenM
Reported side effects in trials include: Nausea Vomiting Diarrhea Constipation Reduced appetite Mild heart rate increase These are similar to other GLP-1based medications
[DOI] [PubMed] [Google Scholar] 143.Vella A, et al
For example, Mounjaro and Zepbound contain tirzepatide, which activates both GLP-1 and GIP receptors
US$ 28.18
US$ 29.22
US$ 25.61
US$ 23.50
US$ 21.14
US$ 28.94
US$ 22.61
US$ 25.87
US$ 27.59
